Neos Therapeutics Lp Revenue and Competitors

Dallas, TX USA

Location

$156.3M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • Neos Therapeutics Lp's estimated annual revenue is currently $3.7M per year.(i)
  • Neos Therapeutics Lp's estimated revenue per employee is $100,500
  • Neos Therapeutics Lp's total funding is $156.3M.

Employee Data

  • Neos Therapeutics Lp has 37 Employees.(i)
  • Neos Therapeutics Lp grew their employee count by 0% last year.

Neos Therapeutics Lp's People

NameTitleEmail/Phone
1
CFOReveal Email/Phone
2
VP OperationsReveal Email/Phone
3
VP, Human ResourcesReveal Email/Phone
4
Head ADHD MarketingReveal Email/Phone
5
VP Trade SalesReveal Email/Phone
6
VP Clinical AffairsReveal Email/Phone
7
Associate Director Supply ChainReveal Email/Phone
8
CEO and DirectorReveal Email/Phone
9
DEA Compliance ManagerReveal Email/Phone
10
Manager, OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$26.7M13320%N/AN/A
#2
$13.5M676%N/AN/A
#3
$16.1M80-2%N/AN/A
#4
$62.5M0N/AN/AN/A
#5
$10.1M506%N/AN/A
#6
$119.4M59427%N/AN/A
#7
$22.9M1148%N/AN/A
#8
$92.9M4628%N/AN/A
#9
$11.3M56-8%N/AN/A
#10
$7M356%N/AN/A
Add Company

What Is Neos Therapeutics Lp?

The Neos Therapeutics team is dedicated to creating high-quality products and partnering with pharmaceutical and consumer healthcare companies to address key medical needs. Neos Therapeutics’ research and development (R&D) and fully integrated state of the art, FDA approved manufacturing facility is located in the Dallas/Fort Worth area.

keywords:N/A

$156.3M

Total Funding

37

Number of Employees

$3.7M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Neos Therapeutics Lp News

2022-04-20 - Attention-Deficit Hyperactivity Disorder Market Size, Scope And ...

... Outlook | Eli Lily & Company, Pfizer, Johnson & Johnson Services, Lupin, Shire, Mallinckrodt, Prude Pharma L.P., NEOS Therapeutics Inc.

2022-04-19 - Form DEF 14A Tango Therapeutics, Inc. For: Jun 08

The board of directors of Tango Therapeutics, Inc. is using this proxy ... Our named executive officers, or the NEOs, for 2021 who appear in...

2022-04-06 - Form PREC14A Adagio Therapeutics, Filed by: MITHRIL II LP

Form PREC14A Adagio Therapeutics, Filed by: MITHRIL II LP ... (ii) each of our named executive officers (“NEOs”) included in the Summary...

2015-02-25 - Neos Therapeutics Completes $20.6M Funding Round

Neos Therapeutics, Inc., a Grand Prairie, TX-based specialty pharmaceutical company with a late-stage pipeline of innovative extended-release products for Attention-Deficit Hyperactivity Disorder (ADHD), completed a $20.6m round of funding. Backers included Presidio Partners, Crabtree Partners, ...

2014-04-23 - Neos Therapeutic Raises $22.5M

Neos Therapeutics, Inc., a Grand Prairie, TX-based oral drug delivery company with a portfolio of proprietary technologies and a late-stage pipeline of innovative controlled release (CR) products for ADHD, raised $22.5m in financing. It included a $20m loan facility with Hercules Technology Gro ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.3M3719%N/A
#2
$9.3M400%N/A
#3
$4.9M4111%N/A
#4
$11M432%N/A
#5
$10.5M438%N/A